StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Manas Jaiswal

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Intraday)3 Jul 2026, 2:16 pm ISTvia CNBC Awaaz.

Entry₹1,129.7Inferred
Target₹1,160
Total upside +2.68% (call closed)
Stop loss₹1,114-1.39% risk
At expiry₹1,141.13 Jul 2026, 3:20 pm
Expired+1.01%
Follow Manas Jaiswal for new calls(11% target hit, 148 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:03 am IST
4 supporting0 opposing
Supports the BUY call (4)

Zydus Lifesciences Limited has signed an MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test (MCD) in India.

NSE · Press Release·3 Jul · today

(opens in new tab)

Zydus Lifesciences Ltd. has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to expand access to the Shield™ Multi-Cancer Detection test (MCD) in India. This test screens for 10 common

BSE · Company Update·3 Jul · today

(opens in new tab)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·3 Jul · today

Zydus Lifesciences Ltd provided an update on the acquisition of an API business.

BSE · Company Update·29 Jun · 4d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Manas Jaiswal

Every call and its outcome